title: Abnormal Paneth cell granule dissolution and compromised resistance to bacterial colonization in the intestine of CF mice.
abstract: Paneth cells of intestinal crypts contribute to host defense by producing antimicrobial peptides that are packaged as granules for secretion into the crypt lumen. Here, we provide evidence using light and electron microscopy that postsecretory Paneth cell granules undergo limited dissolution and accumulate within the intestinal crypts of cystic fibrosis (CF) mice. On the basis of this finding, we evaluated bacterial colonization and expression of two major constituents of Paneth cells, i.e., alpha-defensins (cryptdins) and lysozyme, in CF murine intestine. Paneth cell granules accumulated in intestinal crypt lumens in both untreated CF mice with impending intestinal obstruction and in CF mice treated with an osmotic laxative that prevented overt clinical symptoms and mucus accretion. Ultrastructure studies indicated little change in granule morphology within mucus casts, whereas granules in laxative-treated mice appear to undergo limited dissolution. Protein extracts from CF intestine had increased levels of processed cryptdins compared with those from wild-type (WT) littermates. Nonetheless, colonization with aerobic bacteria species was not diminished in the CF intestine and oral challenge with a cryptdin-sensitive enteric pathogen, Salmonella typhimurium, resulted in greater colonization of CF compared with WT intestine. Modest downregulation of cryptdin and lysozyme mRNA in CF intestine was shown by microarray analysis, real-time quantitative PCR, and Northern blot analysis. Based on these findings, we conclude that antimicrobial peptide activity in CF mouse intestine is compromised by inadequate dissolution of Paneth cell granules within the crypt lumens.
authors.affiliation: Dalton Cardiovascular Research Center and Departmentof Biomedical Sciences, University of Missouri, Columbia, 65211, USA. clarkel@missouri.edu
authors.forename: Lane L
authors.initials: LL
authors.lastname: Clarke
authors.forename: Lara R
authors.initials: LR
authors.lastname: Gawenis
authors.forename: Emily M
authors.initials: EM
authors.lastname: Bradford
authors.forename: Louise M
authors.initials: LM
authors.lastname: Judd
authors.forename: Kathryn T
authors.initials: KT
authors.lastname: Boyle
authors.forename: Janet E
authors.initials: JE
authors.lastname: Simpson
authors.forename: Gary E
authors.initials: GE
authors.lastname: Shull
authors.forename: Hiroki
authors.initials: H
authors.lastname: Tanabe
authors.forename: Andre J
authors.initials: AJ
authors.lastname: Ouellette
authors.forename: Craig L
authors.initials: CL
authors.lastname: Franklin
authors.forename: Nancy M
authors.initials: NM
authors.lastname: Walker
mesh_terms: D000818:Animals; D001419:Bacteria / Q000254:growth & development* / Q000276:immunology* / Q000302:isolation & purification; D001420:Bacteria, Aerobic / Q000302:isolation & purification; D001424:Bacterial Infections / Q000276:immunology / Q000382:microbiology; D015169:Colony Count, Microbial; D003594:Cytoplasmic Granules / Q000648:ultrastructure*; D015536:Down-Regulation; D007413:Intestinal Mucosa / Q000378:metabolism; D007422:Intestines / Q000276:immunology* / Q000382:microbiology / Q000648:ultrastructure; D051379:Mice; D018181:Mice, Inbred CFTR; D008854:Microscopy, Electron; D008871:Microvilli / Q000648:ultrastructure; D009113:Muramidase / Q000235:genetics; D019879:Paneth Cells / Q000276:immunology* / Q000648:ultrastructure*; D010446:Peptide Fragments / Q000378:metabolism; D011498:Protein Precursors / Q000235:genetics / Q000378:metabolism; D012333:RNA, Messenger / Q000378:metabolism; D012486:Salmonella typhimurium / Q000254:growth & development / Q000276:immunology
chemical_list: D010446:Peptide Fragments; D011498:Protein Precursors; D012333:RNA, Messenger; C059569:cryptdin; D009113:Muramidase